| Feb 6 2023 |
The RADV Final Rule and Advance Notice of CY 2024 Capitation Rates: Provider Considerations |
Nelson Mullins |
| Feb 6 2023 |
Title 22 is Governing Law in California – Think Twice Before Adopting a Three-Year Practitioner Reappointment Cycle |
Polsinelli PC |
| Feb 6 2023 |
DOJ Withdraws Long-Standing Health Care Antitrust Enforcement Policy Statements |
Epstein Becker & Green, P.C. |
| Feb 6 2023 |
Consolidated Appropriations Act of 2023 Extends Telehealth Waivers |
K&L Gates LLP |
| Feb 6 2023 |
Cardiology: The New Darling of Private Equity Investment |
Foley & Lardner LLP |
| Feb 6 2023 |
Operation Nightingale: Fraudulent Nursing Diploma Scheme and Its Implications on Health Care |
Mintz |
| Feb 6 2023 |
2024 New York Budget Proposes Wide-Ranging Transaction Approval Requirement That Targets Private Investment in Physician Practices and MSOs, and Permits DOH to Extract Concessions |
Proskauer Rose LLP |
| Feb 3 2023 |
CMS Finalizes Long-Awaited Rule on Medicare Advantage RADV Audits |
McDermott Will & Schulte LLP |
| Feb 3 2023 |
Beltway Buzz, February 3, 2023 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 3 2023 |
Attention New York Medicaid Providers: It’s Time to Upgrade Your Compliance Program |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 3 2023 |
$31 Million Medicare Fraud Scheme Results in Two Convictions |
ArentFox Schiff LLP |
| Feb 3 2023 |
GoodRx to Pay $1.5 Million in First Ever FTC Health Breach Notification Rule Enforcement Action |
Hunton Andrews Kurth |
| Feb 3 2023 |
Additional Nelson Mullins Alerts |
Nelson Mullins |
| Feb 2 2023 |
President Biden Announces the End of the COVID-19 Emergencies: The Health Care Industry Has Less Than Four Months to Prepare |
Proskauer Rose LLP |
| Feb 2 2023 |
CMS’s Final Rule on Medicare Advantage Risk Adjustment Data Validation |
Epstein Becker & Green, P.C. |
| Feb 2 2023 |
COVID-19 May Be Over, but Fight Over the Federal Contractor Vaccine Mandate Is Not |
Bradley Arant Boult Cummings LLP |
| Feb 2 2023 |
New Nursing Home Inspection Reporting Policy Seeks to Foster Transparency, But Will It Cause More Confusion? |
Nelson Mullins |
| Feb 2 2023 |
7 Key Value-Adding LOI Terms |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 2 2023 |
Podcast: The PACE Program – What Changes May Be Coming Soon? – Diagnosing Health Care |
Epstein Becker & Green, P.C. |
| Feb 2 2023 |
New Group Practice Information Form for the Stark Law’s Self-Referral Disclosure Protocol |
Mintz |
| Feb 2 2023 |
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products |
McDermott Will & Schulte LLP |
| Feb 2 2023 |
Death by One Thousand ‘Instances’: OSHA’s New Instance-by-Instance Penalty Policy |
Greenberg Traurig, LLP |
| Feb 2 2023 |
OSHA Begins 2023 with an Emphasis on Enforcement |
Beveridge & Diamond PC |
| Feb 1 2023 |
CMS Issues Long-Awaited Medicare Advantage RADV Final Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 1 2023 |
Private Equity and Digital Health in 2023: Policy Updates and Trends to Watch |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 1 2023 |
If at First You Don’t Succeed: Updated Medical Cannabis Bill Filed in South Carolina |
Bradley Arant Boult Cummings LLP |
| Feb 1 2023 |
The New Hart-Scott-Rodino Magic Number is $111.4 million, and Big Changes in HSR Filing Fees |
Polsinelli PC |
| Jan 31 2023 |
Court Rules in Favor of Manufacturers in 340B Contract Pharmacy Case |
McDermott Will & Schulte LLP |
| Jan 31 2023 |
Old North State Report – Jan. 30, 2023 |
Nelson Mullins |
| Jan 31 2023 |
Louisiana Insurance Department Issues Cease and Desist Orders to a TPA and the Louisiana Office of Group Benefits for Failure to Pay Rx Claims in a Timely Manner |
Polsinelli PC |
| Jan 31 2023 |
The Transformation in Behavioral Digital Health Services |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 31 2023 |
Home Health and Hospice – A Look at Value-Based Initiatives Underway in 2023 |
Nelson Mullins |
| Jan 31 2023 |
ARE YOU AFFECTED BY THE PROPOSED CMS GUIDELINES? If You Purchase Leads, Sell Leads Or Are Involved In Marketing, Then YES! |
Troutman Amin, LLP |
| Jan 31 2023 |
FDA Issues Orphan Drug Exclusivity Policy That Could Be a Catalyst for Future Litigation |
Epstein Becker & Green, P.C. |
| Jan 31 2023 |
A New Normal? Omnibus Bill Extends High Deductible Health Plan Telehealth Safe Harbor |
Proskauer Rose LLP |
